Adage Capital Partners
FPRX

Adage Capital Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-900,000
Closed -$15.3M 1088
2020
Q4
$15.3M Buy
+900,000
New +$15.3M 0.03% 494
2020
Q2
Sell
-250,000
Closed -$568K 819
2020
Q1
$568K Hold
250,000
﹤0.01% 696
2019
Q4
$1.15M Sell
250,000
-1,000,000
-80% -$4.59M ﹤0.01% 677
2019
Q3
$4.84M Buy
1,250,000
+50,000
+4% +$194K 0.01% 630
2019
Q2
$7.24M Buy
1,200,000
+50,000
+4% +$302K 0.02% 567
2019
Q1
$15.4M Buy
1,150,000
+250,000
+28% +$3.35M 0.04% 444
2018
Q4
$8.37M Buy
900,000
+252,000
+39% +$2.34M 0.02% 538
2018
Q3
$9.02M Sell
648,000
-42,000
-6% -$585K 0.02% 561
2018
Q2
$10.9M Sell
690,000
-110,000
-14% -$1.74M 0.03% 545
2018
Q1
$13.7M Sell
800,000
-500,000
-38% -$8.59M 0.03% 492
2017
Q4
$28.5M Sell
1,300,000
-1,132,700
-47% -$24.8M 0.06% 329
2017
Q3
$99.5M Sell
2,432,700
-61,300
-2% -$2.51M 0.24% 110
2017
Q2
$75.1M Sell
2,494,000
-96,000
-4% -$2.89M 0.18% 159
2017
Q1
$93.6M Buy
2,590,000
+690,000
+36% +$24.9M 0.24% 117
2016
Q4
$95.2M Sell
1,900,000
-225,100
-11% -$11.3M 0.26% 102
2016
Q3
$112M Sell
2,125,100
-241,900
-10% -$12.7M 0.31% 85
2016
Q2
$97.9M Sell
2,367,000
-233,000
-9% -$9.63M 0.27% 106
2016
Q1
$106M Buy
2,600,000
+275,000
+12% +$11.2M 0.29% 98
2015
Q4
$96.5M Sell
2,325,000
-339,949
-13% -$14.1M 0.25% 118
2015
Q3
$41M Buy
2,664,949
+701,457
+36% +$10.8M 0.11% 231
2015
Q2
$48.8M Buy
1,963,492
+350,208
+22% +$8.7M 0.12% 225
2015
Q1
$36.9M Buy
1,613,284
+693,402
+75% +$15.8M 0.09% 285
2014
Q4
$24.8M Buy
919,882
+419,882
+84% +$11.3M 0.06% 358
2014
Q3
$5.87M Buy
500,000
+412,597
+472% +$4.84M 0.01% 597
2014
Q2
$1.36M Buy
+87,403
New +$1.36M ﹤0.01% 666